Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Catalent Inc
(NY:
CTLT
)
59.55
-0.26 (-0.43%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Catalent Inc
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Eli Lilly, Novo Nordisk Could Be First Trillion-Dollar Drug Stocks
February 06, 2024
Thanks to weight loss and obesity drugs, Eli Lilly and Novo Nordisk could become the first trillion-dollar stocks in the pharma industry.
Via
InvestorPlace
Catalent Analysts Raise Their Forecasts Following Acquisition News
February 06, 2024
On Monday, Catalent, Inc. (NYSE: CTLT) announced it will be acquired by Novo Holdings. Novo Holdings will acquire all outstanding shares of Catalent for $63.50 per share in cash.
Via
Benzinga
Uber To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday
February 06, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Why Catalent Stock Soared Today
February 05, 2024
Catalent has agreed to be acquired by Novo Nordisk's parent company.
Via
The Motley Fool
Why Novo Nordisk Stock Crushed the Market on Monday
February 05, 2024
The pharmaceutical giant will receive three manufacturing facilities from its parent company's latest acquisition.
Via
The Motley Fool
Analyst Expectations For Catalent's Future
January 25, 2024
Via
Benzinga
What Happened With Caltalent Stock?
December 19, 2023
Catalent, Inc. (NYSE: CTLT) shares traded higher on Tuesday. Following losses at the end of October, the stock has rebounded over the past month.
Via
Benzinga
What 9 Analyst Ratings Have To Say About Catalent
November 16, 2023
Via
Benzinga
Recap: Catalent Q1 Earnings
November 15, 2023
Via
Benzinga
Stocks Fall As Traders Dial Back Rate Cut Bets; Dollar, Treasury Yields Rise: What's Driving Markets Monday?
February 05, 2024
Wall Street ends week on negative note as traders revise down expectations on Fed rate cuts. Strong economic data and Fed officials' comments push stocks into red, reducing rate cut expectations for...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Amgen Is Trying To Take On Lilly, Novo In Obesity Treatment — Here's Why Lilly Stock Just Hit A Record
February 05, 2024
Amgen is looking to rival Eli Lilly and Novo Nordisk in weight-loss drugs.
Via
Investor's Business Daily
What's Going On With Eli Lilly Stock Today?
February 05, 2024
Eli Lilly's stock surge, driven by the upcoming Q4 2023 results and the impact of FDA-approved weight-loss drug Zepbound.
Via
Benzinga
Catalent (CTLT) Stock Pops 10% on Sale to Novo Nordisk
February 05, 2024
Catalent stock is rising higher on Monday after the company announced a $16.5 billion cash acquisition deal for CTLT shares.
Via
InvestorPlace
Preview: Catalent's Earnings
November 14, 2023
Via
Benzinga
Why Air Products and Chemicals Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
February 05, 2024
Shares of Air Products and Chemicals, Inc. (NYSE: APD) fell sharply during Monday’s session after the company reported worse-than-expected first-quarter financial results and lowered FY24 adjusted EPS...
Via
Benzinga
Estée Lauder Posts Upbeat Earnings, Joins ON Semiconductor, Tyson Foods And Other Big Stocks Moving Higher On Monday
February 05, 2024
U.S. stocks traded lower, with the Dow Jones falling over 300 points on Monday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Ozempic Maker Strikes $11B Deal With Catalent As It Rushes To Meet Massive Weight-Loss Drug Demand
February 05, 2024
This move comes on the heels of the company's recent collaborations to develop new treatment approaches for obesity management and chronic liver diseases.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
February 05, 2024
The biggest pre-market stock movers are starting off the trading week as we check out all of the hottest news for Monday morning!
Via
InvestorPlace
S&P 500 Shatters Records: The Top-Performing Stocks In January 2024
January 19, 2024
2023 was a historical milestone for S&P 500 as it once again surpassed record highs, largely due to tech giants and artificial intelligence. Top gainers were NVIDIA, Meta Platforms, and AMD.
Via
Benzinga
Topics
Artificial Intelligence
Stocks
Exposures
Artificial Intelligence
US Equities
These 9 Stocks Are Running To Start 2024
January 14, 2024
The S&P 500 is up just 0.2% in 2024. These stocks are off to a strong start.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Jim Cramer: Buy This Financial Stock, 'I Think They're High Quality'
November 30, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Vishay Intertechnology, Inc.
Via
Benzinga
Intel To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Thursday
November 16, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Catalent's Q1 Performance Beat Expectations: Analyst Says Main Focus On Manufacturing Outlook For Sarepta's Gene Therapy
November 15, 2023
Catalent Inc's (NYSE: CTLT) Q1 FY24 revenue of $982 million decreased 4% as reported, or 6%, in constant currency, beating the
Via
Benzinga
Target Reports Earnings Beat, Joins AST SpaceMobile, Dada Nexus And Other Big Stocks Moving Higher On Wednesday
November 15, 2023
U.S. stocks traded higher, with the Dow Jones gaining more than 100 points on Wednesday. Shares of Target Corporation (NYSE: TGT) jumped during Wednesday’s session after the company reported...
Via
Benzinga
Topics
Earnings
Stocks
Exposures
Financial
US Equities
US Stocks On Track To Build On Gains As Traders Await A Batch Of Data; Can Market Resist Profit Taking?
November 15, 2023
U.S. stocks could build on the momentum they picked up on Tuesday following the release of benign inflation data. Traders get to digest another batch of economic data on producer price inflation,...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
BioMarin Surges As Activist Investor Elliott Reportedly Builds $1 Billion Stake
November 07, 2023
The company's recently FDA-approved gene therapy is struggling to gain traction.
Via
Investor's Business Daily
What's Going On With Biotech Contract Service Firm Catalent Stock Today?
October 31, 2023
Catalent Inc (NYSE: CTLT) shares are trading lower due to its significant exposure to Sarepta Therapeutics Inc (NASDAQ: SRPT) on the back of disappointing data from a pivotal gene therapy trial.
Via
Benzinga
Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
October 31, 2023
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
October 31, 2023
It's time for another busy day of trading as we go over the biggest pre-market stock movers worth watching on Tuesday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
October 30, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.